Pharmaceuticals

Ruscogenins

Ruscus aculeatus L.(Root)≥ 95-103% Ruscogenins By HPLCRuscogenins is a combination of the molecules Ruscogenin and Neoruscogenin. It is used for its anti- elastase, permeability reduction, vasoconstrictive and anti haemorrhoidal properties, and to treat chronic venous insufficiency.The isolated molecule group, Ruscogenins from Ruscus aculeatus, reduces cell permeability through its anti-elastase activity by degrading elastin the main component of the extracellular matrix. Furthermore, in-vivo studies suggest that its vasoconstrictive effect may be mediated by calcium and the alpha-1 adrenergic receptors.This GMP certified pharmaceutical ingredient is supplied with an Active Substance Master File and produced according to European Pharmacopeia.

API designed for pharmaceutical applications. Benefits:Complies with Eur. Ph and USPMeets with cGMP (ICHQ7) compliance

API developed for pharmaceutical applications.  Benefits: Meets with cGMP (ICHQ7) compliance

API designed for pharmaceutical applications.Benefits: Meets with cGMP (ICHQ7) compliance

Characteristics (starting material) : A crystalline powder Compliance with current Eur. Ph. Monography Enzymatic process : no solvents used in the process resulting in higher purity of the product.   General information : Therapeutic use : Broad spectrum penicillin, for veterinary injectable suspensions Storage conditions : Below 25°C, protected from light and moisture

Characteristics (starting material) : A crystalline powder. Compliance with the current Eur. Ph. Monography Enzymatic process : no solvents used in the process resulting in higher purity of the product.   GENERAL INFORMATION : Therapeutical use : Broad spectrum penicillin, for veterinary injectable suspensions Retest date : 18 months after micronization Storage conditions : Below 25°C, protected from light and moisture

Characteristics (starting material) : A crystalline powder Compliance with the current Eur. Ph. Monography Enzymatic process : no solvents used in the process resulting in higher purity of the product.                 GENERAL INFORMATION : Therapeutical use : Broad spectrum penicillin, for veterinary injectable suspensions Storage conditions : Below 25°C, protected from light and moisture

Characteristics (starting material) : A crystalline powder Compliance with the current Eur. Ph. Monography Enzymatic process : no solvents used in the process resulting in higher purity of the product. GENERAL INFORMATION : Therapeutical use : Broad spectrum penicillin, for veterinary injectable suspensions Storage conditions : Below 25°C, protected from light and moisture